67 related articles for article (PubMed ID: 10851485)
1. Pilot ascending dose tolerance study of parenterally administered 4-(2 hydroxyethyl)-1-piperazine ethane sulfonic acid (TVZ-7) in dogs.
Theodore TR; Van Zandt RL; Carpenter RH
Cancer Biother Radiopharm; 1997 Oct; 12(5):345-9. PubMed ID: 10851485
[TBL] [Abstract][Full Text] [Related]
2. Preliminary evaluation of a fixed dose of zwitterionic piperazine (TVZ-7) in clinical cancer.
Theodore TR; Van Zandt RL; Carpenter RH
Cancer Biother Radiopharm; 1997 Oct; 12(5):351-3. PubMed ID: 10851486
[TBL] [Abstract][Full Text] [Related]
3. Toxicity of a quinocarmycin analog, DX-52-1, in rats and dogs in relation to clinical outcome.
Mirsalis JC; Schindler-Horvat J; Hill JR; Green CE; Mitoma C; Tomaszewski JE; Tyson CA; Donohue SJ
Cancer Chemother Pharmacol; 2003 Mar; 51(3):193-201. PubMed ID: 12655436
[TBL] [Abstract][Full Text] [Related]
4. Preclinical toxicity of a geldanamycin analog, 17-(dimethylaminoethylamino)-17-demethoxygeldanamycin (17-DMAG), in rats and dogs: potential clinical relevance.
Glaze ER; Lambert AL; Smith AC; Page JG; Johnson WD; McCormick DL; Brown AP; Levine BS; Covey JM; Egorin MJ; Eiseman JL; Holleran JL; Sausville EA; Tomaszewski JE
Cancer Chemother Pharmacol; 2005 Dec; 56(6):637-47. PubMed ID: 15986212
[TBL] [Abstract][Full Text] [Related]
5. NTP technical report on the toxicity studies of Riddelliine (CAS No. 23246-96-0) Administered by Gavage to F344 Rats and B6C3F1 Mice.
Chan P
Toxic Rep Ser; 1993 Dec; 27():1-D9. PubMed ID: 12209179
[TBL] [Abstract][Full Text] [Related]
6. Copper(II) complexation properties and surfactant activity of 3-[N, N-bis(2-hydroxyethyl)amino]-2-hydroxypropanesulfonic acid and N-(2-Hydroxyethyl)piperazine-N'-2-hydroxypropanesulfonic acid pH buffers which may affect trace metal speciation in in vitro studies.
Vasconcelos MT; Azenha MA; Almeida CM
Anal Biochem; 1998 Dec; 265(2):193-201. PubMed ID: 9882392
[TBL] [Abstract][Full Text] [Related]
7. Investigational new drug-directed toxicology and pharmacokinetic study of 4-[3-(2-nitro-1-imidazolyl)-propylamino]-7-chloroquinoline hydrochloride (NLCQ-1, NSC 709257) in Beagle dogs.
Papadopoulou MV; Bloomer WD; Torti VR; Page JG
Basic Clin Pharmacol Toxicol; 2010 Jun; 106(6):511-22. PubMed ID: 20074266
[TBL] [Abstract][Full Text] [Related]
8. Chronic toxicity of Ponceau SX to rats, mice, and dogs.
Davis KJ; Nelson AA; Zwickey RE; Hansen WH; Fitzhugh OG
Toxicol Appl Pharmacol; 1966 Mar; 8(2):306-17. PubMed ID: 5956881
[No Abstract] [Full Text] [Related]
9. Piperazine-based buffers for liposome coating of capillaries for electrophoresis.
Wiedmer SK; Jussila M; Hakala RM; Pystynen KH; Riekkola ML
Electrophoresis; 2005 May; 26(10):1920-7. PubMed ID: 15825220
[TBL] [Abstract][Full Text] [Related]
10. A two-generation oral gavage reproduction study with potassium perfluorobutanesulfonate (K+PFBS) in Sprague Dawley rats.
Lieder PH; York RG; Hakes DC; Chang SC; Butenhoff JL
Toxicology; 2009 May; 259(1-2):33-45. PubMed ID: 19428941
[TBL] [Abstract][Full Text] [Related]
11. A subchronic intravenous toxicity study of magnesium fructose-1,6-diphosphate in beagle dogs.
Wang M; Yao J; Chen JY; Bai WX; Mei SY; Pan WN; Pan YY; Yu FL
Basic Clin Pharmacol Toxicol; 2009 Feb; 104(2):93-100. PubMed ID: 19053993
[TBL] [Abstract][Full Text] [Related]
12. Toxicity of dolastatin 10 in mice, rats and dogs and its clinical relevance.
Mirsalis JC; Schindler-Horvat J; Hill JR; Tomaszewski JE; Donohue SJ; Tyson CA
Cancer Chemother Pharmacol; 1999; 44(5):395-402. PubMed ID: 10501913
[TBL] [Abstract][Full Text] [Related]
13. Further studies on the toxicity of 2-chloroethyl methanesulfonate (NSC-18016, CB-1506) for the dog.
SCHMIDT LH; LANG JF; MACK HP
Cancer Chemother Rep; 1961 Jun; 12():157-77. PubMed ID: 13748033
[No Abstract] [Full Text] [Related]
14. Respiratory depression and apnea induced by propofol in dogs.
Muir WW; Gadawski JE
Am J Vet Res; 1998 Feb; 59(2):157-61. PubMed ID: 9492929
[TBL] [Abstract][Full Text] [Related]
15. 4-Week repeated intravenous dose toxicity study of a new camptothecin anticancer agent CKD-602 in dogs.
Kim JC; Shin DH; Park SH; Park SC; Kim YB; Kim HC; Cha SW; Cho KH; Kang BH; Chung MK
Food Chem Toxicol; 2005 May; 43(5):699-706. PubMed ID: 15778009
[TBL] [Abstract][Full Text] [Related]
16. Clinical pharmacology of DP-b99 in healthy volunteers: first administration to humans.
Rosenberg G; Angel I; Kozak A
Br J Clin Pharmacol; 2005 Jul; 60(1):7-16. PubMed ID: 15963088
[TBL] [Abstract][Full Text] [Related]
17. Preclinical toxicologic evaluation of ICRF-187 in dogs.
Levine BS; Henry MC; Port CD; Rosen E
Cancer Treat Rep; 1980; 64(12):1211-5. PubMed ID: 6781745
[TBL] [Abstract][Full Text] [Related]
18. The pharmacokinetics of mavacoxib, a long-acting COX-2 inhibitor, in young adult laboratory dogs.
Cox SR; Lesman SP; Boucher JF; Krautmann MJ; Hummel BD; Savides M; Marsh S; Fielder A; Stegemann MR
J Vet Pharmacol Ther; 2010 Oct; 33(5):461-70. PubMed ID: 20840390
[TBL] [Abstract][Full Text] [Related]
19. Preclinical toxicologic evaluation of 2,5-piperazinedione, 3,6-bis(5-chloro-2-piperidyl),-dihydrochloride (NSC-135758) in dogs and monkeys.
Folk RM; Peters AC; Pavkov KL; Swenberg JA
Cancer Chemother Rep 3; 1974 Sep; 5(1):37-41. PubMed ID: 4213303
[No Abstract] [Full Text] [Related]
20. Preclinical toxicology studies with ICRF-159 (NSC-129943)--a new antineoplastic drug.
Gralla EJ; Coleman GL; Jonas AM
Cancer Chemother Rep 3; 1974 Sep; 5(1):1-7. PubMed ID: 4213305
[No Abstract] [Full Text] [Related]
[Next] [New Search]
